Accuray Incorporated (ARAY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 12:59PM EDT. Market open.
| Previous Close | 2.1800 |
| Open | 2.1300 |
| Bid | 1.8200 x 200 |
| Ask | 1.8400 x 100 |
| Day's Range | 1.8350 - 2.1300 |
| 52 Week Range | 1.4000 - 3.1000 |
| Volume | |
| Avg. Volume | 867,035 |
| Market Cap | 182.113M |
| Beta (5Y Monthly) | 1.41 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
ARAY Stock Up Following the Use of SGRT on Cancer Patients in Japan
The latest adoption of Accuray's Radixact System and VitalHold package is likely to improve the care provided to cancer patients and their experience.
- Simply Wall St.
Accuray (NASDAQ:ARAY) shareholders are up 14% this past week, but still in the red over the last three years
Accuray Incorporated ( NASDAQ:ARAY ) shareholders should be happy to see the share price up 17% in the last quarter...
- Zacks
Accuray Stock Rises After Helix System Wins CE Mark for Cancer Care
ARAY's Helix system, now CE Mark approved, aims to close global cancer care gaps with cost-effective, high-throughput radiotherapy for underserved regions.
© 2024 Yahoo. All rights reserved.